Trials of India’s first mRNA Covid vaccine by Gennova on track
Gennova started Phase-I trials last month and has covered 120 volunteers. Gennova Biopharmaceuticals, which is working on India’s first mRNA Covid-19 vaccine, is in the midst of Phase-I trials of its Covid-19 vaccine (HGC019). Vikas Thapar, president – corporate development & strategy, Emcure Pharmaceuticals, said the Phase-I trials will be completed in the next 45-60 … Read more